High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study.

[1]  R. Veazey,et al.  Impaired Development and Expansion of Germinal Center Follicular Th Cells in Simian Immunodeficiency Virus–Infected Neonatal Macaques , 2018, The Journal of Immunology.

[2]  P. Goulder,et al.  Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia , 2018, AIDS.

[3]  A. Sohn,et al.  The global epidemiology of adolescents living with HIV: time for more granular data to improve adolescent health outcomes , 2018, Current opinion in HIV and AIDS.

[4]  S. De Wit,et al.  Prevalence and risk factors of measles seronegativity in a cohort of HIV‐positive subjects: a retrospective study , 2018, HIV medicine.

[5]  D. Harris,et al.  Immunity After Childhood Vaccinations in Perinatally HIV-exposed Children With and Without HIV Infection in Latin America , 2017, The Pediatric infectious disease journal.

[6]  B. Chohan,et al.  Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya , 2017, The Pediatric infectious disease journal.

[7]  P. Offit,et al.  Plotkin's Vaccines , 2017 .

[8]  C. Rizzo,et al.  Global seroprevalence of rubella among pregnant and childbearing age women: a meta-analysis , 2017, European journal of public health.

[9]  C. Strassburg,et al.  Measles, mumps, rubella and VZV: importance of serological testing of vaccine-preventable diseases in young adults living with HIV in Germany , 2016, Epidemiology and Infection.

[10]  N. French,et al.  British HIV Association Guidelines on the Use of Vaccines in HIV‐Positive Adults 2015 , 2016, HIV medicine.

[11]  C. Bergin,et al.  High levels of susceptibility to measles, mumps and rubella (MMR) in HIV-infected individuals in Ireland. , 2016, The Journal of infection.

[12]  H. Young,et al.  Interruptions of antiretroviral therapy in children and adolescents with HIV infection in clinical practice: a retrospective cohort study in the USA , 2016, Journal of the International AIDS Society.

[13]  M. Majigo,et al.  Serological makers of rubella infection in Africa in the pre vaccination era: a systematic review , 2015, BMC Research Notes.

[14]  A. Rieger,et al.  High need for MMR vaccination in HIV infected adults in Austria. , 2014, Vaccine.

[15]  P. Böelle,et al.  Long-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  P. Heath,et al.  Guidance on vaccination of HIV‐infected children in Europe , 2012, HIV medicine.

[17]  N. Low,et al.  Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. , 2011, The Journal of infectious diseases.

[18]  R. Succi,et al.  Pregnancy in HIV vertically infected adolescents and young women: a new generation of HIV-exposed infants , 2010, AIDS.

[19]  L. Aurpibul,et al.  Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Best,et al.  RUBELLA VACCINES , 1979, The Lancet.